Alpha Teknova (TKNO) Expected to Announce Earnings on Wednesday

Alpha Teknova (NASDAQ:TKNO) is projected to post its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect Alpha Teknova to announce earnings of ($0.06) per share and revenue of $11.71 million for the quarter. Parties may review the information on the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 6:00 PM ET.

Alpha Teknova (NASDAQ:TKNO) last announced its earnings results on Wednesday, August 5th. The company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.02. Alpha Teknova had a negative net margin of 38.37% and a negative return on equity of 24.94%. The firm had revenue of $12.19 million for the quarter, compared to the consensus estimate of $10.95 million. On average, analysts expect Alpha Teknova to post ($0.28) EPS for the current fiscal year and ($0.23) EPS for the next fiscal year.

Alpha Teknova Stock Up 4.1%

TKNO traded up $0.29 during trading on Tuesday, reaching $7.30. The company had a trading volume of 6,102 shares, compared to its average volume of 257,789. The company has a debt-to-equity ratio of 0.21, a current ratio of 4.49 and a quick ratio of 3.48. Alpha Teknova has a 12 month low of $1.91 and a 12 month high of $9.48. The business’s fifty day moving average price is $7.71 and its 200 day moving average price is $4.90. The company has a market cap of $392.03 million, a P/E ratio of -23.34 and a beta of 0.85.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on TKNO shares. Jefferies Financial Group started coverage on shares of Alpha Teknova in a report on Thursday, September 17th. They set a “buy” rating and a $9.00 price objective on the stock. Wall Street Zen upgraded Alpha Teknova from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. BTIG Research upgraded shares of Alpha Teknova from a “neutral” rating to a “buy” rating and set a $8.00 price objective on the stock in a report on Tuesday, August 11th. Weiss Ratings lowered Alpha Teknova from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. Finally, TD Cowen increased their price target on shares of Alpha Teknova from $7.00 to $11.00 and gave the company a “buy” rating in a research note on Tuesday, October 13th. Four investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $8.75.

Alpha Teknova Company Profile

Alpha Teknova, Inc is a life sciences company that develops and manufactures critical reagents and other products used in biomedical research, biopharmaceutical development and advanced therapies. The company provides laboratory and production materials designed to support applications including cell and gene therapy, molecular diagnostics, next-generation sequencing, vaccine development and pharmaceutical manufacturing.

Its offerings include research-use-only and current Good Manufacturing Practice (cGMP) reagents, buffers, media and other custom-formulated solutions.